Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

MF Global and PFG: the lasting impact on CTAs / CPOs

Thursday, March 28, 2013

By: Mark Melin, Editor Opalesque Futures Intelligence

James A., who wishes to remain anonymous, was an emerging Commodity Trading Advisor (CTA) with a bright future. A quant and trading application developer, he established his public investment CTA product in 2008 with a partner, according to regulatory records. The firm traded an algorithmic model that had shown promise during the market environment of price persistence. Assets under management were growing as the firm received its first institutional allocation, a significant point in an emerging manager’s development.

Then MF Global hit.

James said the large institutional investor was stunned that no explanation could be made as to where his investment capital had gone. The institutional investor had made a substantial allocation to a pool of dozens of CTA with the help of a consultant who knew the CTA space. After the experience, the investor appears scared from the experience.

"He’s been burned. This is still an issue. It’s not a one off event," James said, noting the reputational damage done to the managed futures industry has been significant."

In the wake of MF Global fallout, he refocused his energy into a consulting firm which provides data capture services and conducts algorithmic strategy development, modeling and rendering services for hedge funds, quantitative traders operating in a custom API environment. H......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its